Detalhe da pesquisa
1.
Recommendations for the management of the vascular involvement in Behçet's disease by the Japanese National Research Committee for Behçet's disease-secondary publication.
Mod Rheumatol
; 34(1): 182-193, 2023 Dec 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36658731
2.
The association of Behçet's syndrome with HLA-B51 as understood in 2021.
Curr Opin Rheumatol
; 34(1): 4-9, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34690278
3.
Trial of Apremilast for Oral Ulcers in Behçet's Syndrome.
N Engl J Med
; 381(20): 1918-1928, 2019 11 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31722152
4.
Behçet's disease and activities of daily living.
Rheumatology (Oxford)
; 61(3): 1133-1140, 2022 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34146088
5.
Should we reconsider the definition of elderly-onset rheumatoid arthritis in an ageing society?
Mod Rheumatol
; 32(2): 323-329, 2022 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34894251
6.
Clinical features of Behçet's disease patients with joint symptoms in Japan: A national multicenter study.
Mod Rheumatol
; 32(6): 1146-1152, 2022 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34850090
7.
Apremilast in a Japanese subgroup with Behçet's syndrome: Results from a Phase 3, randomised, double-blind, placebo-controlled study.
Mod Rheumatol
; 32(2): 413-421, 2022 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34894266
8.
Beneficial effects of apremilast on genital ulcers, skin lesions, and arthritis in patients with Behçet's disease: A systematic review and meta-analysis.
Mod Rheumatol
; 32(6): 1153-1162, 2022 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34752620
9.
Apremilast for oral ulcers associated with active Behçet's syndrome over 68 weeks: long-term results from a phase 3 randomised clinical trial.
Clin Exp Rheumatol
; 39 Suppl 132(5): 80-87, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34622764
10.
Efficacy and safety of apremilast for 3 months in Behçet's disease: A prospective observational study.
Mod Rheumatol
; 31(4): 856-861, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32996801
11.
HLA-A26 is a risk factor for Behçet's disease ocular lesions.
Mod Rheumatol
; 31(1): 214-218, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31851572
12.
Positioning of apremilast in treatment of Behçet's disease.
Mod Rheumatol
; 30(2): 219-224, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31747804
13.
miR-1 is a novel biomarker for polymyositis/dermatomyositis-associated interstitial lung disease.
Mod Rheumatol
; 30(5): 878-883, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31483179
14.
The influence of HLA-B51 on clinical manifestations among Japanese patients with Behçet's disease: A nationwide survey.
Mod Rheumatol
; 30(4): 708-714, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31386589
15.
Immune Checkpoint Inhibitor-Induced Myositis: a Case Report and Literature Review.
Curr Rheumatol Rep
; 21(4): 10, 2019 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-30790071
16.
The ocular involvement did not accompany with the genital ulcer or the gastrointestinal symptoms at the early stage of Behçet's disease.
Mod Rheumatol
; 29(2): 357-362, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-29583036
17.
Clinical features of early-stage possible Behçet's disease patients with a variant-type major organ involvement in Japan.
Mod Rheumatol
; 29(4): 640-646, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-29954241
18.
Dysfunction of TRIM21 in interferon signature of systemic lupus erythematosus.
Mod Rheumatol
; 28(6): 993-1003, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-29385873
19.
Clinical manifestations of Behçet's disease depending on sex and age: results from Japanese nationwide registration.
Rheumatology (Oxford)
; 56(11): 1918-1927, 2017 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28968732
20.
On-demand ultrasonography assessment in the most symptomatic joint supports the 8-joint score system for management of rheumatoid arthritis patients.
Mod Rheumatol
; 27(2): 257-265, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-27409294